Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 249 publications
Overall Survival After Sentinel Lymph Node Biopsy Versus Axillary Lymph Node Dissection in Patients With Three Recorded Positive Nodes: A National Cancer Database Analysis.
Journal: Clinical breast cancer
Published: June 05, 2026
Regional Disparities in Socioeconomic Factors and Advanced-stage Presentation in Melanoma: A National Cancer Database Analysis (2004-2020).
Journal: Anticancer research
Published: June 02, 2026
Mechanisms of Local Aggressiveness Without Metastasis in Dermatofibrosarcoma Protuberans.
Journal: Anticancer research
Published: April 25, 2026
Geographic Disparities in Socioeconomic Factors and Advanced-stage Presentation in Rectosigmoid Cancer: A National Cancer Database Analysis.
Journal: Anticancer research
Published: April 19, 2026
Factors Associated With Refusal of Surgery for PDAC and Its Impact: An NCDB Analysis.
Journal: Anticancer research
Published: February 25, 2026
ASO Visual Abstract: Surgical Oncologists for Sustainability-A Statement from the SSO Surgical Oncologists for Sustainability Committee.
Journal: Annals of surgical oncology
Published: December 04, 2025
De-Escalating Surgery for 1-2 cm Appendiceal Neuroendocrine Tumors: A North American Multi-Center Analysis.
Journal: Journal of surgical oncology
Published: November 06, 2025
Invited Commentary: Persistence of Healthcare Disparities in Pancreatic Surgery for Cancer in the US.
Journal: Journal of the American College of Surgeons
Published: November 06, 2025
ASO Author Reflections:Bringing Sustainability to the Forefront of Surgical Oncology.
Journal: Annals of surgical oncology
Published: November 05, 2025
Geographic Variations in Demographics, Socioeconomic Status, and Stage at Diagnosis Among Hormone Receptor-positive Invasive Ductal Carcinoma: An NCDB Analysis (2004-2020).
Journal: Anticancer research
Published: October 30, 2025
Case Report: durable response to pulsed electric field ablation in combination with immune checkpoint inhibitors in HER2-low breast cancer through activation of interferon signaling.
Journal: Frontiers in oncology
Published: August 06, 2025
Last Updated: 09/26/2026